Cargando…
Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis
Background Multiple sclerosis (MS) is an autoimmune and demyelinating inflammatory disease that affects the central nervous system (CNS). The etiology of the disease remains unknown. Multiple theories highlight genetic, environmental, and infectious factors that may a role. MS is considered as the m...
Autores principales: | Alshamrani, Foziah, Alnajashi, Hind, Almuaigel, Mohammed F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077152/ https://www.ncbi.nlm.nih.gov/pubmed/32206459 http://dx.doi.org/10.7759/cureus.6995 |
Ejemplares similares
-
Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
por: Alshamrani, Foziah, et al.
Publicado: (2020) -
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
por: Alshamrani, Foziah, et al.
Publicado: (2021) -
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022) -
Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis
por: Bashamakh, Lujain F., et al.
Publicado: (2019) -
Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience
por: Alnajashi, Hind A., et al.
Publicado: (2018)